|By Marketwired .||
|June 24, 2014 06:12 AM EDT||
LONDON, ONTARIO -- (Marketwired) -- 06/24/14 -- Sernova Corp. (TSX VENTURE: SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of chronic diseases such as diabetes and haemophilia announced today that it is participating at the US BIO International Convention in San Diego, June 23-26th.
"This is an excellent occasion for Sernova to present to international institutions, pharma and potential collaborators to update attendees on our progress and pipeline," remarked Dr. Philip Toleikis, President and CEO.
The convention is an important annual business development forum which allows high-level executives and influential decision makers attending BIO to liaise with key players in the industry, form partnerships, and evaluate emerging technologies.
"Sernova's entire business development team is attending and has numerous one-on-one meetings booked to discuss its proprietary platform - many important collaborations mark their origins to BIO," remarked Kevin Egan, chair of Sernova's Business Advisory Board.
Sernova Corp. is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cells) which then release proteins and/or hormones as required. The therapeutic cells are protected from immune attack by Sernova's proprietary technologies.
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Sernova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of Sernova's management on the date such statements were made. Sernova expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Jul. 7, 2015 10:30 PM EDT Reads: 2,462
Jul. 7, 2015 10:15 PM EDT Reads: 1,145
Jul. 7, 2015 09:30 PM EDT Reads: 1,127
Jul. 7, 2015 08:00 PM EDT Reads: 893
Jul. 7, 2015 07:00 PM EDT Reads: 2,660
Jul. 7, 2015 07:00 PM EDT Reads: 2,622
Jul. 7, 2015 05:45 PM EDT Reads: 2,506
Jul. 7, 2015 05:00 PM EDT Reads: 2,310
Jul. 7, 2015 05:00 PM EDT Reads: 2,498
Jul. 7, 2015 05:00 PM EDT Reads: 2,280
Jul. 7, 2015 04:45 PM EDT Reads: 1,744
Jul. 7, 2015 04:15 PM EDT Reads: 815
Jul. 7, 2015 04:00 PM EDT Reads: 1,979
"In the IoT space we are helping customers, mostly enterprises and industry verticals where time-to-value is critical, and we help them with the ability to do faster insights and actions using our platform so they can transform their business operations," explained Venkat Eswara, VP of Marketing at Vitria, in this SYS-CON.tv interview at @ThingsExpo, held June 9-11, 2015, at the Javits Center in New York City.
Jul. 7, 2015 03:45 PM EDT Reads: 999
Jul. 7, 2015 03:45 PM EDT Reads: 2,423